No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands.

Verburgh, Myrthe L; van der Valk, Marc; Rijnders, Bart J A; Reiss, Peter; Wit, Ferdinand W N M

Verburgh, Myrthe L; van der Valk, Marc; Rijnders, Bart J A; Reiss, Peter; Wit, Ferdinand W N M.

Affiliation

Verburgh ML; Amsterdam UMC location University of Amsterdam.
van der Valk M; Amsterdam Institute for Infection and Immunity, Infectious Diseases.
Rijnders BJA; Amsterdam Public Health, Global Health.
Reiss P; Amsterdam Institute for Global Health and Development.
Wit FWNM; Amsterdam UMC location University of Amsterdam.

AIDS ; 37(9): 1481-1486, 2023 07 15.

Article in En | MEDLINE | ID: mdl-37395254

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / COVID-19 Type of study: Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2023 Document type: Article Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google